These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 22801957

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Management of localized gastrointestinal stromal tumors and adjuvant therapy with imatinib.
    López RL, del Muro XG.
    Anticancer Drugs; 2012 Jun; 23 Suppl():S3-6. PubMed ID: 22739667
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Adherence to imatinib therapy in patients with gastrointestinal stromal tumors.
    Blay JY, Rutkowski P.
    Cancer Treat Rev; 2014 Mar; 40(2):242-7. PubMed ID: 23931926
    [Abstract] [Full Text] [Related]

  • 8. Adjuvant imatinib treatment after R0 resection for patients with high-risk gastrointestinal stromal tumors: a median follow-up of 44 months.
    Jiang WZ, Guan GX, Lu HS, Yang YH, Kang DY, Huang HG.
    J Surg Oncol; 2011 Dec; 104(7):760-4. PubMed ID: 21713778
    [Abstract] [Full Text] [Related]

  • 9. Adjuvant therapy for high-risk gastrointestinal stromal tumour: considerations for optimal management.
    Joensuu H.
    Drugs; 2012 Oct 22; 72(15):1953-63. PubMed ID: 22994537
    [Abstract] [Full Text] [Related]

  • 10. Adjuvant imatinib therapy for gastrointestinal stromal tumors.
    Pisters PW, Colombo C.
    J Surg Oncol; 2011 Dec 22; 104(8):896-900. PubMed ID: 22069174
    [Abstract] [Full Text] [Related]

  • 11. [Efficacy observation on imatinib adjuvant therapy with longer duration in patients with gastrointestinal stromal at intermediate or high risk of recurrence].
    Li J, Dang YZ, Gao J, Shen L.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Mar 22; 16(3):216-20. PubMed ID: 23536338
    [Abstract] [Full Text] [Related]

  • 12. New fronts in the adjuvant treatment of GIST.
    Reichardt P, Joensuu H, Blay JY.
    Cancer Chemother Pharmacol; 2013 Oct 22; 72(4):715-23. PubMed ID: 23934322
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Congestive heart failure in a 77-year-old woman receiving adjuvant treatment with imatinib for a large gastric gastrointestinal stromal tumour.
    Pulido EG, Riquelme A, Ballesteros J, Vaz MÁ.
    Anticancer Drugs; 2012 Jun 22; 23 Suppl():S15-7. PubMed ID: 22739666
    [Abstract] [Full Text] [Related]

  • 16. Gastric antral vascular ectasia in a patient with GIST after treatment with imatinib: case report and literature review.
    Saad Aldin E, Mourad F, Tfayli A.
    Jpn J Clin Oncol; 2012 May 22; 42(5):447-50. PubMed ID: 22422898
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Hepatitis B viral reactivation secondary to imatinib treatment in a patient with gastrointestinal stromal tumor.
    Walker EJ, Simko JP, Ko AH.
    Anticancer Res; 2014 Jul 22; 34(7):3629-34. PubMed ID: 24982379
    [Abstract] [Full Text] [Related]

  • 20. Practical management of imatinib in gastrointestinal stromal tumors.
    Barnes T, Reinke D.
    Clin J Oncol Nurs; 2011 Oct 22; 15(5):533-45. PubMed ID: 21951740
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.